BPC-157 and TB-500: Research Comparison
The table below synthesizes the primary differences in structure, mechanism, and research application between BPC-157 and TB-500 to guide peptide selection for specific experimental models. Molecular Weight 1,419 Da (15 amino acids) 4,963 Da (43 amino acids) B
This comparison does not assign a generated winner or score.
- The table below synthesizes the primary differences in structure, mechanism, and research application between BPC-157 and TB-500 to guide peptide selection for specific experimental models.
- Molecular Weight
- 1,419 Da (15 amino acids)
- 4,963 Da (43 amino acids)
- BPC-157's smaller size enables faster local tissue penetration; TB-500's larger structure correlates with longer systemic half-life
- Primary Mechanism
- VEGF upregulation, angiogenesis, nitric oxide pathway modulation
- Actin monomer sequestration, NF-κB downregulation, cell migration promotion
- Non-overlapping pathways—BPC-157 is vascular-focused; TB-500 is cytoskeletal and immune-focused
- Origin
- Synthetic sequence from gastric protective protein BPC
- Synthetic fragment of thymosin beta-4 (naturally occurring in most cells)
- BPC-157 is gut-derived and acid-stable; TB-500 is immune-origin and systemically distributed
- Blood-Brain Barrier
- Limited to no permeability
- Crosses BBB effectively
- TB-500 is suitable for CNS injury models; BPC-157 is not
- Half-Life (Preclinical)
- 4–6 hours tissue residence
- 10–12 hours plasma half-life
- TB-500 requires less frequent dosing in sustained-release models
- Optimal Tissue Types
- Tendons, ligaments, GI mucosa, vascular-limited injuries
- Muscle, cardiac, diffuse inflammation, systemic tissue damage
- Match peptide to injury mechanism—vascular vs inflammatory
- Administration Route
- Oral, subcutaneous, intraperitoneal (acid-stable)
- Subcutaneous, intramuscular (degrades in gastric environment)
- BPC-157 tolerates oral routes; TB-500 requires injection
- Typical Research Dose
- 10–500 mcg/kg body weight
- 5–20 mg per dose (varies by model)
- Dose ranges are not directly comparable due to different mechanisms